Pyridinium Cross-links in Multiple Myeloma: Correlation with Clinical Parameters and Use for Monitoring of Intravenous Clodronate Therapy--A Pilot Study of the German Myeloma Treatment Group (GMTG)

By Peest D.   Deicher H.   Fett W.   Harms P.   Braun H.J.   Planker M.   Kindler U.   Klinkenstein C.   Schafer E.   Schumacher K.   Siecke H.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2053-2057

Elsevier

Access to resources Recommend Favorite

Bisphosphonates - Mechanisms of Action in Multiple Myeloma

By Shipman Claire M.   Rogers Michael J.   Vanderkerken Karin   Van Camp Ben   Russell R. Graham G.   Croucher Peter I.  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 829-835

Informa Healthcare

Access to resources Recommend Favorite

Mechanism of action of immunomodulatory agents in multiple myeloma

By Reske Thomas   Fulciniti Mariateresa   Munshi Nikhil  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 7-13

Humana Press, Inc

Access to resources Recommend Favorite

N-telopeptide of type I collagen is useful for monitoring therapeutic response in non-small cell lung cancer patients with bone metastases

By Kaira Rieko   Murakami Haruyasu   Kaira Kyoichi   Takahashi Toshiaki   Tsuya Asuka   Nakamura Yukiko   Naito Tateaki   Endo Masahiro   Yamamoto Nobuyuki  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 484-488

Springer Publishing Company

Access to resources Recommend Favorite

Sjogren's Syndrome and Multiple Myeloma

By Rodriguez-Cuartero A.   Salas-Galan A.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 167-168

Elsevier

Access to resources Recommend Favorite